Well To Do

Well To Do

Roundup: Brands in Trouble, New Niche Markets & More

Ozempic continues to inspire new programs, while brands discover an overlooked influencer market. Plus: new snore-detecting tech?

Rina Raphael
Feb 02, 2024
∙ Paid
Photo by Victor Freitas on Unsplash

I oversaw health and wellness features at a media company that very publicly imploded this week. I’m still recovering from the mayhem, so, uh, just the links this week! 

Once I’ve calmed down, I might write up what I witnessed there. Till then, I will be taking my own advice and seeking some self-care (most likely by watching 30 Rock reruns).

As always, if you’d like to support this newsletter, do consider a full subscription.
—Rina Raphael

News & Trends:

A new fitness market for Ozempic users: The potential loss of lean muscle mass has inspired a new fitness sector. Brands like Noom, Obe, and more are adding muscle-enhancement programs. (Altechnews)

Can illness trackers become as big as fitness trackers? Visible is a tracker that monitors long COVID, chronic conditions, and cancer recovery. (TechCrunch)

Peloton shares hit all-time low: Shares plummet 24%, sparking alarm about the fitness tech platform’s future. (CNBC)

Target wants a bigger piece of the wel…

User's avatar

Continue reading this post for free, courtesy of Rina Raphael.

Or purchase a paid subscription.
© 2026 Rina Raphael · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture